{"listing":{"listing_type":"company","name":"Invitris","slug":"invitris","tagline":"Creating new protein-based drugs at scale","description":"Invitris radically simplifies how we create novel biological drugs. Our patent-pending technology platform turns DNA into synthetic proteins and was recently featured in the Science magazine. It makes creating new drugs >10,000x more efficient at <100x lower costs of material.\n\nOur killer application is enabling the newest generation of synthetic bacteriophages to combat antibiotic-resistant infections, which are threatening to cause more deaths than all cancers combined.\n\nInvitris is a Y Combinator company (Winter 2023). YC-listed status: Active.","url":"https://www.invitris.com/","is_stealth":false,"normalized_domain":"invitris.com","normalized_url_key":"invitris.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/b31c6e14e61e0a7e292383c88d7094914a492565.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/invitris","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.invitris.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.invitris.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Drug Discovery and Delivery","Biotech","Nanotechnology","Drug discovery"],"stage":null,"founded_year":null,"location":"Munich, BY, Germany","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T07:28:16.195Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Winter 2023","Biotech","Nanotechnology","Drug discovery"],"one_liner_for_search":"Invitris — Creating new protein-based drugs at scale (Y Combinator Winter 2023)","canonical_facts":["Y Combinator batch: Winter 2023","YC company status: Active","Team size (per YC directory): 6","YC industry: Healthcare","YC subindustry: Healthcare / Drug Discovery and Delivery","Regions (per YC): Germany, Europe, Remote, Partly Remote"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T07:28:16.195Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"drug-discovery","name":"Drug discovery","note":null,"profile_url":"/industries/drug-discovery"},{"kind":"industry","slug":"drug-discovery-and-delivery","name":"Drug Discovery and Delivery","note":null,"profile_url":"/industries/drug-discovery-and-delivery"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"nanotechnology","name":"Nanotechnology","note":null,"profile_url":"/industries/nanotechnology"}]}}